ACCENDRA HEALTH INC/VA/
Calidad de datos: 83%
ACH
NYSE
Wholesale Trade
Durable Goods Wholesale
$3.33
▲
$0.18
(5.71%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-27.11%
Crecimiento
Revenue Growth (5Y)
-27.11%
Below sector avg (2.60%)
Revenue (1Y)-74.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC1.42%
Net Margin-39.85%
Op. Margin0.99%
Seguridad
Debt / Equity
N/A
Current Ratio0.86
Interest Coverage0.26
Valoración
PE (TTM|NTM|2027)
-0.18 | 3.03 | 2.56
Below sector avg (-0.16)
P/B RatioN/A
EV/EBITDA0.70
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -27.11% annually over 5 years
Revenue growth is decelerating — 1Y growth trails 5Y average by 47.08%
Capital efficient — spends only 6.91% of revenue on capex
ROIC of 1.42% — low return on invested capital
Interest coverage of 0.26× — tight debt servicing
16 consecutive years of dividends — reliable payer
Price History
Tendencias Financieras
Precio Objetivo de Analistas
5 analistas
Hold
-2.4%
upside to target
Actual
$3.33
Consensus Target
$3.25
$2.25
Mín
$5.00
Máx
Pronóstico
P/E Futuro
3.03
EPS Futuro
$1.04
Crecimiento EPS (est.)
+55.4%
Ingresos Est.
2.71 B
Sorpresas de Ganancias
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -$0.10
·
Rev Est: 644.64 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | $0.23 | $0.26 | $0.25 | $0.21 | — | — |
| Estimate | $0.20 | $0.28 | $0.24 | $0.22 | -$0.10 | $0.12 |
| Sorpresa | +14.45% | -5.73% | +6.39% | -5.05% | — | — |
Growth
Rev 5Y: -27.11% · Earnings 1Y: N/A
Growth
Rev 5Y: -27.11% · Earnings 1Y: N/A| Revenue Growth (1Y) | -74.19% | Revenue Growth (3Y) | -48.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -27.11% | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: -39.85%
Profitability
ROE: N/A · Net Margin: -39.85%| Revenue (TTM) | 2.76 B | Net Income (TTM) | -1.10 B |
| ROE | N/A | ROA | -26.88% |
| Gross Margin | N/A | Operating Margin | 0.99% |
| Net Margin | -39.85% | Free Cash Flow (TTM) | N/A |
| ROIC | 1.42% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 0.86
Safety
D/E: N/A · Current: 0.86| Debt / Equity | N/A | Current Ratio | 0.86 |
| Interest Coverage | 0.26 | Asset Turnover | 0.67 |
| Working Capital | -334.29 M | Tangible Book Value | -1.82 B |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | -75.88% | Dividend Growth (5Y) | -58.87% |
| Consecutive Div Years | 16 yrs | ||
Valuation
P/E: -0.18 · EV/EBITDA: 0.70
Valuation
P/E: -0.18 · EV/EBITDA: 0.70| P/E Ratio | -0.18 | Forward P/E | 3.03 |
| P/B Ratio | N/A | P/S Ratio | 0.07 |
| PEG Ratio | N/A | Forward PEG | 0.05 |
| EV/EBITDA | 0.70 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.08 | Fwd Earnings Yield | 33.00% |
| FCF Yield | N/A | ||
| Market Cap | 202.94 M | Enterprise Value | 170.11 M |
Per Share
EPS: -14.31 · FCF/Share: N/A
Per Share
EPS: -14.31 · FCF/Share: N/A| EPS (Diluted TTM) | -14.31 | Revenue / Share | 36.13 |
| FCF / Share | N/A | OCF / Share | N/A |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: N/A · CapEx/Rev: 6.91%
Efficiency
FCF Conv: N/A · CapEx/Rev: 6.91%| CapEx / Revenue | 6.91% | FCF Conversion | N/A |
| SBC-Adj. FCF | N/A | Growth Momentum | -47.08 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.76 B | 10.70 B | 10.33 B | 9.96 B | 9.79 B |
| Net Income | -1.10 B | -362.69 M | -41.30 M | 22.39 M | 221.59 M |
| EPS (Diluted) | -14.31 | -4.73 | -0.54 | 0.29 | 2.94 |
| Gross Profit | — | 2.22 B | 2.13 B | 1.83 B | 1.51 B |
| Operating Income | 27.46 M | -207.77 M | 104.51 M | 142.91 M | 368.47 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | 13.00 M | 13.20 M | — | — |
| SG&A Expenses | 1.07 B | 1.91 B | 1.81 B | 1.63 B | 1.12 B |
| D&A | 214.52 M | 264.78 M | 287.38 M | 228.67 M | 90.62 M |
| Interest Expense | 107.18 M | 143.80 M | 157.92 M | 128.89 M | 48.09 M |
| Income Tax | 729,000.0 | 5.33 M | -13.43 M | -11.50 M | 55.17 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.45 B | 4.66 B | 5.09 B | 5.39 B | 3.54 B |
| Total Liabilities | 2.91 B | 4.09 B | 4.17 B | 4.44 B | 2.60 B |
| Shareholders' Equity | -460.98 M | 565.23 M | 924.17 M | 945.60 M | 938.50 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 281.99 M | 49.38 M | 243.04 M | 69.47 M | 55.71 M |
| Current Assets | 547.87 M | 2.02 B | 2.10 B | 2.30 B | 2.32 B |
| Current Liabilities | 947.08 M | 1.87 B | 1.89 B | 1.57 B | 1.34 B |
Comparación con Pares
vs mediana del sector Wholesale Trade (100 pares)
Comparado con empresas similares en Wholesale Trade
Comparación con Pares
vs mediana del sector Wholesale Trade (100 pares) Comparado con empresas similares en Wholesale Trade| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.2 | -0.2 |
| P/B | — | 1.0 |
| ROE % | — | -3.2 |
| Net Margin % | -39.9 | -2.4 |
| Rev Growth 5Y % | -27.1 | 2.6 |
| D/E | — | 0.3 |
Historial de Dividendos
Historial de Dividendos
Pagos recientes por acción (más reciente primero).
| Ex-dividendo | Pago | Monto / acción |
|---|---|---|
| Dec 14, 2021 | — | $0.00 |
| Sep 14, 2021 | — | $0.00 |
| Jun 14, 2021 | — | $0.00 |
| Mar 12, 2021 | — | $0.00 |
| Dec 14, 2020 | — | $0.00 |
| Sep 14, 2020 | — | $0.00 |
| Jun 12, 2020 | — | $0.00 |
| Mar 13, 2020 | — | $0.00 |
| Dec 13, 2019 | — | $0.00 |
| Sep 13, 2019 | — | $0.00 |
| Jun 13, 2019 | — | $0.00 |
| Mar 14, 2019 | — | $0.00 |
{"event":"ticker_viewed","properties":{"ticker":"ACH","listing_kind":"stock","pathname":"/stocks/ach","exchange":"NYSE","country":"US"}}